| Akari Therapeutics Plc (AKTX) |
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 |
| Balance Sheet Date | | | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | | |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | | |
| Close Price of Common Stock | 4.39$ | 0.12$ | 0.29$ | 0.99$ | 1.19$ | 1.27$ | 1.20$ | 3.05$ | 2.95$ | 1.78$ | 3.06$ | 4.08$ | 0.17$ | 0.18$ | 0.49$ | 0.61$ | 0.95$ | 1.20$ | 1.50$ | 1.63$ | 1.71$ | 2.63$ | 1.84$ | 1.73$ | 2.19$ | 1.47$ | 1.78$ | 1.71$ | 2.13$ | 3.60$ | 1.68$ | 2.25$ | 1.97$ | 1.74$ | 4.45$ | 6.14$ | | | | | | | | | | | | | |
| Market Cap of Common Stock | 401,979,171,850$ | 11,253,585,472$ | 20,371,646,534$ | 64,675,011,100$ | 76,579,760,032$ | 62,886,736,714$ | 59,420,538,628$ | 72,916,043,545$ | 46,749,804,993$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | 3,472.01% | (44.76%) | (68.50%) | (15.55%) | 21.77% | 5.83% | (18.51%) | 55.97% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 424.92% | (82.11%) | (65.72%) | (11.30%) | 63.81% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | | 91,567,009,533 | 90,536,879,533 | 65,229,461,523 | 65,229,461,523 | 57,752,981,523 | 53,186,919,523 | 24,289,231,523 | 24,289,232,698 | 15,973,121,298 | 13,234,315,298 | 10,125,005,923 | 10,122,321,523 | 10,111,583,823 | 7,444,917,123 | | | | 4,759,731,923 | | | | | | | | | | | | | | | | | | | | | | 1,177,693,383 | 1,177,693,383 | 1,177,693,383 | 1,177,693,383 | 55,636,283 | 55,636,283 | 722,345,600 | 73,370,267 | 55,636,283 |
| QoQ% | | 1.14% | 38.80% | .00% | 12.95% | 8.59% | 118.97% | .00% | 52.06% | 20.70% | 30.71% | .03% | .11% | 35.82% | | | | | | | | | | | | | | | | | | | | | | | | | | | .00% | .00% | .00% | 2,016.77% | .00% | (92.30%) | 884.52% | 31.88% | 12.46% |
| YoY% | | 58.55% | 70.22% | 168.55% | 168.55% | 261.56% | 301.89% | 139.89% | 139.96% | 57.97% | 77.76% | | | | 56.42% | | | | | | | | | | | | | | | | | | | | | | | | | | 2,016.77% | 2,016.77% | 63.04% | 1,505.14% | .00% | 12.46% | 1,695.63% | | |